Who Owns Geron Stock?
NASDAQ: GERNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 73.53%
- Held by insiders
- 0.09%
- Institutional holders
- 325
- Institutions 73.5%
- Insiders 0.1%
- Public and other 26.4%
Who owns Geron stock?
Institutional investors own about 73.5% of Geron's shares, spread across 325 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.09% of GERN.
The largest institutional holders are Blackrock Inc. (7.85%), Soleus Capital Management, L.P. (7.26%) and RA Capital Management, L.P. (6.64%). Together, the top 10 institutions control 45.1% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their GERN positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of GERN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 50.57M | 7.85% | +3.0% |
| Soleus Capital Management, L.P. | 46.77M | 7.26% | +9.3% |
| RA Capital Management, L.P. | 42.75M | 6.64% | -0.1% |
| State Street Corporation | 31.90M | 4.95% | -11.0% |
| Vanguard Capital Management LLC | 27.67M | 4.30% | +1.6% |
| Citadel Advisors Llc | 24.30M | 3.77% | -16.3% |
| ClearBridge Investments, LLC | 19.70M | 3.06% | +0.3% |
| Eversept Partners, LP | 18.53M | 2.88% | -1.0% |
| Geode Capital Management, LLC | 14.27M | 2.22% | -2.0% |
| Nantahala Capital Management, LLC | 13.87M | 2.15% | +13.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of GERN
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 20.45M | 3.17% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 18.06M | 2.80% |
| iShares Trust-iShares Russell 2000 ETF | 14.35M | 2.23% |
| Vanguard Explorer Fund | 12.98M | 2.01% |
| Legg Mason Partners Investment Trust-ClearBridge Small Cap Growth Fund | 6.32M | 0.98% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 6.12M | 0.95% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 6.11M | 0.95% |
| iShares Trust-iShares Russell 2000 Growth ETF | 5.29M | 0.82% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 4.99M | 0.77% |
| iShares Trust-iShares Biotechnology ETF | 4.96M | 0.77% |
Frequently asked questions
Who is the largest shareholder of Geron?
Blackrock Inc. is the largest institutional shareholder of GERN, owning 7.85% of shares outstanding (50.57M shares) as of its latest 13F filing.
What percentage of Geron is owned by institutions?
Institutions own about 73.5% of GERN shares and 73.6% of the public float.
How much of Geron do insiders own?
Insiders, such as officers and directors, own about 0.09% of GERN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.